Open access · OA
via OpenAlex
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E. Gegg, Derek Burke, Simon Heales, Jonathan M. Cooper, John Hardy, Nicholas Wood, Anthony H.V. Schapira
Annals of Neurology · 2012 · ▲ 572 citations
Abstract
OBJECTIVE: Mutations in the glucocerebrosidase gene (GBA) represent a significant risk factor for developing Parkinson disease (PD). We investigated the enzymatic activity of glucocerebrosidase (GCase) in PD brains carrying heterozygote GBA mutations (PD+GBA) and sporadic PD brains. METHODS: GCase activity was measured using a fluorescent assay in cerebellum, frontal cortex, putamen, amygdala, and substantia nigra of PD+GBA (n = 9-14) and sporadic PD brains (n = 12-14). Protein expression of GCase and other lysosomal proteins was determined by western blotting. The relation between GCase, α-synuclein, and mitochondria function was also investigated in vitro. RESULTS: A significant decrease in GCase activity was observed in all PD+GBA brain areas except the frontal cortex. The greatest deficiency was in the substantia nigra (58% decrease; p < 0.01). GCase activity was also significantly decreased in the substantia nigra (33% decrease; p < 0.05) and cerebellum (24% decrease; p < 0.05) of sporadic PD brains. GCase protein expression was lower in PD+GBA and PD brains, whereas increased C/EBP homologous protein and binding immunoglobulin protein levels indicated that the unfolded protein response was activated. Elevated α-synuclein levels or PTEN-induced putative kinase 1 deficiency in cultured cells had a significant effect on GCase protein levels. INTERPRETATION: GCase deficiency in PD brains with GBA mutations is a combination of decreased catalytic activity and reduced protein levels. This is most pronounced in the substantia nigra. Biochemical changes involved in PD pathogenesis affect wild-type GCase protein expression in vitro, and these could be contributing factors to the GCase deficiency observed in sporadic PD brains.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/ana.23614
- Canonical
- link ↗
- Fetched
- 2026-06-03 MST
Cite this
APA
Gegg, M.E., Burke, D., Heales, S., Cooper, J.M., Hardy, J., Wood, N., & Schapira, A.H. (2012). Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. <em>Annals of Neurology</em>. https://doi.org/10.1002/ana.23614
Vancouver
Gegg ME, Burke D, Heales S, Cooper JM, Hardy J, Wood N, et al. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Annals of Neurology. 2012. doi:10.1002/ana.23614.
BibTeX
@article{matthew2012Glucoc,
title = {Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains},
author = {Matthew E. Gegg and Derek Burke and Simon Heales and Jonathan M. Cooper and John Hardy and Nicholas Wood and Anthony H.V. Schapira},
journal = {Annals of Neurology},
year = {2012},
doi = {10.1002/ana.23614},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging Neuroscience 2019
Open access · CC-BY
Gi/o-Protein Coupled Receptors in the Aging Brain
FEBS Letters 2014
Open access · OA
Inhibition of miR‐34b and miR‐34c enhances α‐synuclein expression in Parkinson's disease
npj Parkinson s Disease 2023
Open access · CC-BY
C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain
Zenodo (CERN European Organization for Nuclear Research) 2026
Preprint · CC-BY
EFFECT OF SPERMIDINE ON THE EXPRESSION OF EXTRACELLULAR MATRIX PROTEINS AND AUTOPHAGY MARKERS IN HUMAN LUNG FIBROBLASTS
Movement Disorders 2006
Open access · OA
Levels of alpha‐synuclein mRNA in sporadic Parkinson disease patients
2021
Open access · OA